PepGen shifts focus to PGN-EDODM1 for Myotonic Dystrophy Type 1 after discontinuing PGN-EDO51 for Duchenne Muscular Dystrophy ...
Sparrow Bioacoustics Inc. closed a C$10 million (US$7.15 million) financing round to support continued adoption of its U.S. FDA-cleared Stethophone platform, which allows bioacoustics detection of ...
Good afternoon, and welcome to Sarepta's Third Quarter 2025 Financial Results Conference Call. As a reminder, today's program is being recorded. At this time, I'll turn the call over to Tam Thornton, ...
News Medical on MSN
N6-Methyladenosine: New Target for Acute Lung Injury
Acute lung injury (ALI) is a critical clinical condition characterized by diffuse inflammation of the lung parenchyma and intractable hypoxemia ...
Correcting And Replacing Wave Life Sciences Announced Positive Target Engagement Data From INLIGHT Clinical Trial Of WVE-007 For Obesity During Annual Research Day. This press release corrects and ...
Constative on MSN
22 Nobel Prize Winners Who Changed the Way We Live
Every time a doctor orders a CT scan, or a child receives a lifesaving vaccine, or your phone’s GPS corrects itself by the ...
9hon MSN
Molecular dynamics simulations use atomistic force field to capture RNA folding with high accuracy
Ribonucleic acid (RNA) is one of life's most versatile molecules, with roles going far beyond being a messenger of genetic ...
Presentation will highlight preclinical data supporting the potential of WVE-007 (INHBE GalNAc-siRNA) as a unique approach for the treatment of obesity designed to drive fat loss while preserving musc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback